“…Final analyses took place in Leiden, the Netherlands. The initial sample consisted of 251 SAD-patients and 230 healthy control (HC)-participants ( Table 1 ), and results on these datasets have been published previously ( Boehme et al, 2015 , Boehme et al, 2014a , Boehme et al, 2014b , Cremers et al, 2014 , Geiger et al, 2016 , Howells et al, 2015 , Klumpp et al, 2016 , Månsson et al, 2015 , Månsson et al, 2013 , Pannekoek et al, 2013 , Phan et al, 2013 , Syal et al, 2012 , van Tol et al, 2010 ) – see Inline Supplementary Document 1 for more details on the in- and exclusion criteria and recruitment of participants for each sample. At each site, the local ethical committee approved data-collection and all participants provided written informed consent after the procedure had been fully explained.…”